117 related articles for article (PubMed ID: 9404818)
1. Etomidate inhibits [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells.
Sikand KS; Hirota K; Smith G; Lambert DG
Neurosci Lett; 1997 Oct; 236(2):87-90. PubMed ID: 9404818
[TBL] [Abstract][Full Text] [Related]
2. Effects of propofol and thiopentone on potassium- and carbachol-evoked [3H]noradrenaline release and increased [Ca2+]i from SH-SY5Y human neuroblastoma cells.
Lambert DG; Willets JM; Atcheson R; Frost C; Smart D; Rowbotham DJ; Smith G
Biochem Pharmacol; 1996 Jun; 51(12):1613-21. PubMed ID: 8687476
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic (M1) receptor-mediated inhibition of K(+)-evoked [3H]-noradrenaline release from human neuroblastoma (SH-SY5Y) cells via inhibition of L- and N-type Ca2+ channels.
McDonald RL; Vaughan PF; Peers C
Br J Pharmacol; 1994 Oct; 113(2):621-7. PubMed ID: 7834216
[TBL] [Abstract][Full Text] [Related]
4. The effect of protein kinase C activation on muscarinic-M3- and K(+)-evoked release of [3H]noradrenaline and increases in intracellular Ca2+ in human neuroblastoma SH-SY5Y cells.
Murphy NP; McCormack JG; Ball SG; Vaughan PF
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):645-50. PubMed ID: 1554348
[TBL] [Abstract][Full Text] [Related]
5. Effect of halothane on K+ and carbachol stimulated [3H]noradrenaline release and increased [Ca2+]i in SH-SY5Y human neuroblastoma cells.
Atcheson R; Bjornstrom K; Hirst RA; Rowbotham DJ; Lambert DG
Br J Anaesth; 1997 Jul; 79(1):78-83. PubMed ID: 9301393
[TBL] [Abstract][Full Text] [Related]
6. The effect of calcium channel antagonists on the release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y.
Murphy NP; Ball SG; Vaughan PF
Neurosci Lett; 1991 Aug; 129(2):229-32. PubMed ID: 1745405
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism of [3H]-noradrenaline release from SH-SY5Y cells: the role of Ca2+ and cyclic AMP.
Atcheson R; Lambert DG; Hirst RA; Rowbotham DJ
Br J Pharmacol; 1994 Mar; 111(3):787-92. PubMed ID: 8019757
[TBL] [Abstract][Full Text] [Related]
8. The effect of barium on [3H]noradrenalin release from the human neuroblastoma SH-SY5Y.
Vaughan PF; Kaye DF; Ball SG; Reeve HL; Peers C
Eur J Neurosci; 1995 May; 7(5):875-80. PubMed ID: 7613623
[TBL] [Abstract][Full Text] [Related]
9. Potassium- and carbachol-evoked release of [3H]noradrenaline from human neuroblastoma cells, SH-SY5Y.
Murphy NP; Ball SG; Vaughan PF
J Neurochem; 1991 May; 56(5):1810-5. PubMed ID: 1901596
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin-evoked release of [3H]noradrenaline from the human neuroblastoma SH-SY5Y.
McDonald RL; Kaye DF; Reeve HL; Ball SG; Peers C; Vaughan PF
Biochem Pharmacol; 1994 Jul; 48(1):23-30. PubMed ID: 8043027
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
Taglialatela M; Secondo A; Fresi A; Rosati B; Pannaccione A; Castaldo P; Giorgio G; Wanke E; Annunziato L
Biochem Pharmacol; 2001 Nov; 62(9):1229-38. PubMed ID: 11705456
[TBL] [Abstract][Full Text] [Related]
12. Effect of inhibitors of eicosanoid metabolism on release of [3H]noradrenaline from the human neuroblastoma, SH-SY5Y.
Vaughan PF; Murphy MG; Ball SG
J Neurochem; 1993 Apr; 60(4):1365-71. PubMed ID: 8455030
[TBL] [Abstract][Full Text] [Related]
13. Fentanyl inhibits the release of [3H]noradrenaline from SH-SY5Y human neuroblastoma cells.
Atcheson R; Rowbotham DJ; Lambert DG
Br J Anaesth; 1994 Jan; 72(1):98-103. PubMed ID: 8110561
[TBL] [Abstract][Full Text] [Related]
14. A role for protein kinase C subtypes alpha and epsilon in phorbol-ester-enhanced K(+)- and carbachol-evoked noradrenaline release from the human neuroblastoma SH-SY5Y.
Turner NA; Rumsby MG; Walker JH; McMorris FA; Ball SG; Vaughan PF
Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):407-13. PubMed ID: 8297348
[TBL] [Abstract][Full Text] [Related]
15. The Na+-Ca2+ exchange inhibitor KB-R7943 inhibits high K+-induced increases in intracellular Ca2+ concentration and [3H]noradrenaline release in the human neuroblastoma SH-SY5Y.
Nakamura H; Kawasaki Y; Arakawa N; Saeki M; Maeda S; Koyama Y; Baba A; Matsuda T
Neurochem Res; 2000 Mar; 25(3):385-7. PubMed ID: 10761983
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
Connor M; Yeo A; Henderson G
Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
[TBL] [Abstract][Full Text] [Related]
17. The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release.
Vaughan PF; Peers C; Walker JH
Gen Pharmacol; 1995 Oct; 26(6):1191-201. PubMed ID: 7590107
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia enhances [3H]noradrenaline release evoked by nicotinic receptor activation from the human neuroblastoma SH-SY5Y.
Wade JA; Vaughan PF; Peers C
J Neurochem; 1998 Oct; 71(4):1482-9. PubMed ID: 9751181
[TBL] [Abstract][Full Text] [Related]
19. Mobilization of inositol 1,4,5-trisphosphate-sensitive Ca2+ stores supports bradykinin- and muscarinic-evoked release of [3H] noradrenaline from SH-SY5Y cells.
Purkiss JR; Nahorski SR; Willars GB
J Neurochem; 1995 Mar; 64(3):1175-82. PubMed ID: 7861149
[TBL] [Abstract][Full Text] [Related]
20. Potassium- and carbachol-evoked released of [3H]noradrenaline from human neuroblastoma cells, SH-SY5Y.
Murphy NP; Ball SG; Vaughan PF
Biochem Soc Trans; 1990 Jun; 18(3):436-7. PubMed ID: 2115463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
